A detailed history of Windsor Group LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Windsor Group LTD holds 53,054 shares of LLY stock, worth $42.2 Million. This represents 5.22% of its overall portfolio holdings.

Number of Shares
53,054
Previous 60,500 12.31%
Holding current value
$42.2 Million
Previous $28.4 Million 0.44%
% of portfolio
5.22%
Previous 5.09%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 24, 2023

SELL
$434.7 - $599.3 $3.24 Million - $4.46 Million
-7,446 Reduced 12.31%
53,054 $28.5 Million
Q2 2023

Jul 12, 2023

SELL
$350.74 - $468.98 $196,063 - $262,159
-559 Reduced 0.92%
60,500 $28.4 Million
Q1 2023

Apr 19, 2023

SELL
$310.63 - $364.82 $201,288 - $236,403
-648 Reduced 1.05%
61,059 $22.4 Million
Q4 2022

Feb 01, 2023

SELL
$321.55 - $374.67 $101,609 - $118,395
-316 Reduced 0.51%
61,707 $22.4 Million
Q3 2022

Nov 07, 2022

BUY
$296.48 - $337.87 $3,854 - $4,392
13 Added 0.02%
62,023 $20.3 Million
Q2 2022

Aug 08, 2022

SELL
$278.73 - $327.27 $1.38 Million - $1.62 Million
-4,965 Reduced 7.41%
62,010 $20.5 Million
Q1 2022

May 04, 2022

BUY
$234.69 - $291.66 $108,661 - $135,038
463 Added 0.7%
66,975 $20.9 Million
Q4 2021

Jan 21, 2022

BUY
$224.85 - $279.04 $72,851 - $90,408
324 Added 0.49%
66,512 $17.7 Million
Q3 2021

Oct 12, 2021

BUY
$221.6 - $272.71 $65,150 - $80,176
294 Added 0.45%
66,188 $15.2 Million
Q2 2021

Jul 26, 2021

BUY
$180.55 - $233.54 $1.44 Million - $1.86 Million
7,960 Added 13.74%
65,894 $15.1 Million
Q1 2021

May 12, 2021

BUY
$164.32 - $212.72 $227,254 - $294,191
1,383 Added 2.45%
57,934 $10.8 Million
Q4 2020

Feb 09, 2021

SELL
$130.46 - $172.63 $87,930 - $116,352
-674 Reduced 1.18%
56,551 $9.55 Million
Q3 2020

Nov 06, 2020

SELL
$146.22 - $169.13 $357,507 - $413,522
-2,445 Reduced 4.1%
57,225 $8.11 Million
Q2 2020

Jul 06, 2020

BUY
$136.42 - $164.18 $3,001 - $3,611
22 Added 0.04%
59,670 $9.8 Million
Q1 2020

Apr 13, 2020

SELL
$119.05 - $147.35 $732,633 - $906,791
-6,154 Reduced 9.35%
59,648 $8.27 Million
Q4 2019

Jan 07, 2020

BUY
$106.92 - $132.43 $140,706 - $174,277
1,316 Added 2.04%
65,802 $8.65 Million
Q3 2019

Oct 21, 2019

BUY
$106.79 - $116.16 $23,600 - $25,671
221 Added 0.34%
64,486 $7.21 Million
Q2 2019

Jul 15, 2019

BUY
$110.79 - $129.32 $4.09 Million - $4.78 Million
36,948 Added 135.26%
64,265 $7.25 Million
Q1 2019

Apr 09, 2019

SELL
$111.31 - $131.02 $1.04 Million - $1.23 Million
-9,367 Reduced 25.53%
27,317 $3.55 Million
Q4 2018

Jan 15, 2019

BUY
$105.9 - $118.64 $49,773 - $55,760
470 Added 1.3%
36,684 $4.25 Million
Q3 2018

Oct 05, 2018

BUY
$85.86 - $107.31 $278,272 - $347,791
3,241 Added 9.83%
36,214 $3.89 Million
Q2 2018

Jul 31, 2018

SELL
$75.7 - $86.88 $37,168 - $42,658
-491 Reduced 1.47%
32,973 $2.81 Million
Q1 2018

May 09, 2018

SELL
$74.21 - $87.6 $228,789 - $270,070
-3,083 Reduced 8.44%
33,464 $2.59 Million
Q4 2017

Mar 01, 2018

BUY
$81.94 - $87.89 $2.99 Million - $3.21 Million
36,547
36,547 $3.09 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Windsor Group LTD Portfolio

Follow Windsor Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Windsor Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Windsor Group LTD with notifications on news.